Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 years or older
- People who have chest pain (angina) with confirmed reduced blood flow to the heart muscle
- People who have at least one major heart artery that needs a stent placed in it
- People who have signed a consent form agreeing to take part in the study
Who may not be able to join:
- People who are having a certain type of serious heart attack (called an ST-elevation heart attack) at the time of admission
- People who have previously had heart bypass surgery or a heart transplant
- People whose heart pumping function is severely reduced (below 30%) (confirm with trial site)
- People who are in cardiogenic shock, meaning their heart is not pumping enough blood to meet the body's needs
- People whose life expectancy is less than 2 years
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study
- People for whom blood-thinning medications (anti-platelets or heparin) are not safe to use
- People whose artery blockage is in a specific high-risk location called the left main artery
- People whose artery blockage contains a blood clot
- People with a blockage that has formed inside a previously placed stent
- People whose blockage is in a smaller branching artery
- People with a fully blocked artery (chronic total occlusion)
- People with a small artery measuring less than 2.5mm in diameter
- People experiencing coronary artery spasm even after receiving nitrate medication
- People whose artery is too narrow, stiff, or angled for the imaging equipment to pass through safely
- People for whom the imaging during the procedure produces poor quality results
- People who have visible collateral vessels (natural bypass channels) around the blockage
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Seung-Whan Lee, MD, Asan Medical Center
Phone: 82-10-7398-9897
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
culprit-related TVF; nonculprit-related TVF
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.